LOADING
Tag: Moderate
LEO Pharma Presents Late-Breaking Phase 3 Delgocitinib Cream Data in Adolescents with Moderate to Severe Chronic Hand Eczema (CHE) – BioSpace
September 19, 2025
LEO Pharma Presents Late-Breaking Phase 3 Delgocitinib Cream Data in Adolescents with Moderate to Severe Chronic Hand Eczema (CHE) BioSpace Source link
chat_bubble0 Comment
visibility80 Views
Ivarmacitinib Proves Effective in Treating Moderate to Severe Atopic Dermatitis – Docwire News
May 30, 2025
Ivarmacitinib Proves Effective in Treating Moderate to Severe Atopic Dermatitis Docwire News Source link
chat_bubble0 Comment
visibility104 Views
(delgocitinib) Cream in Chinese Patients with Moderate to Severe Chronic Hand Eczema (CHE) – Business Wire
February 27, 2025
(delgocitinib) Cream in Chinese Patients with Moderate to Severe Chronic Hand Eczema (CHE) Business Wire Source link
chat_bubble0 Comment
visibility130 Views
Deucravacitinib Shows Significant Efficacy and Safety in Phase 3b/4 Trial for Moderate to Severe Scalp Psoriasis – Dermatology Times
October 28, 2024
Deucravacitinib Shows Significant Efficacy and Safety in Phase 3b/4 Trial for Moderate to Severe Scalp Psoriasis Dermatology Times Source link
chat_bubble0 Comment
visibility157 Views